These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 32367193)

  • 21. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis.
    Mickle JE; Macek M; Fulmer-Smentek SB; Egan MM; Schwiebert E; Guggino W; Moss R; Cutting GR
    Hum Mol Genet; 1998 Apr; 7(4):729-35. PubMed ID: 9499426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Link Between a Common Mutation in CFTR and Impaired Innate and Adaptive Viral Defense.
    Svedin E; Utorova R; Hühn MH; Larsson PG; Stone VM; Garimella M; Lind K; Hägglöf T; Pincikova T; Laitinen OH; McInerney GM; Scholte B; Hjelte L; Karlsson MCI; Flodström-Tullberg M
    J Infect Dis; 2017 Dec; 216(10):1308-1317. PubMed ID: 28968805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungs.
    Keiser NW; Birket SE; Evans IA; Tyler SR; Crooke AK; Sun X; Zhou W; Nellis JR; Stroebele EK; Chu KK; Tearney GJ; Stevens MJ; Harris JK; Rowe SM; Engelhardt JF
    Am J Respir Cell Mol Biol; 2015 Jun; 52(6):683-94. PubMed ID: 25317669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variant cystic fibrosis phenotypes in the absence of CFTR mutations.
    Groman JD; Meyer ME; Wilmott RW; Zeitlin PL; Cutting GR
    N Engl J Med; 2002 Aug; 347(6):401-7. PubMed ID: 12167682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoring airway epithelial homeostasis in Cystic Fibrosis.
    Cafora M; Chanson M; Pistocchi A
    J Cyst Fibros; 2023 Mar; 22 Suppl 1():S27-S31. PubMed ID: 36216743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations of Cystic Fibrosis Transmembrane Conductance Regulator Gene Cause a Monocyte-Selective Adhesion Deficiency.
    Sorio C; Montresor A; Bolomini-Vittori M; Caldrer S; Rossi B; Dusi S; Angiari S; Johansson JE; Vezzalini M; Leal T; Calcaterra E; Assael BM; Melotti P; Laudanna C
    Am J Respir Crit Care Med; 2016 May; 193(10):1123-33. PubMed ID: 26694899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis.
    Derichs N
    Eur Respir Rev; 2013 Mar; 22(127):58-65. PubMed ID: 23457166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune responses in cystic fibrosis: are they intrinsically defective?
    Ratner D; Mueller C
    Am J Respir Cell Mol Biol; 2012 Jun; 46(6):715-22. PubMed ID: 22403802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation.
    Khan MA; Ali ZS; Sweezey N; Grasemann H; Palaniyar N
    Genes (Basel); 2019 Feb; 10(3):. PubMed ID: 30813645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pseudomonas aeruginosa triggers CFTR-mediated airway surface liquid secretion in swine trachea.
    Luan X; Campanucci VA; Nair M; Yilmaz O; Belev G; Machen TE; Chapman D; Ianowski JP
    Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12930-5. PubMed ID: 25136096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The phenotypic consequences of CFTR mutations.
    Rowntree RK; Harris A
    Ann Hum Genet; 2003 Sep; 67(Pt 5):471-85. PubMed ID: 12940920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystic Fibrosis, CFTR, and Colorectal Cancer.
    Scott P; Anderson K; Singhania M; Cormier R
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deletion of
    Bernut A; Loynes CA; Floto RA; Renshaw SA
    Front Immunol; 2020; 11():1733. PubMed ID: 32849617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetics of cystic fibrosis treatment.
    Carter SC; McKone EF
    Pharmacogenomics; 2016 Aug; 17(13):1453-63. PubMed ID: 27490265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
    Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
    Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations.
    Harutyunyan M; Huang Y; Mun KS; Yang F; Arora K; Naren AP
    Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L529-L543. PubMed ID: 29351449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cystic Fibrosis Lung Immunity: The Role of the Macrophage.
    Bruscia EM; Bonfield TL
    J Innate Immun; 2016; 8(6):550-563. PubMed ID: 27336915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aggregates of mutant CFTR fragments in airway epithelial cells of CF lungs: new pathologic observations.
    Du K; Karp PH; Ackerley C; Zabner J; Keshavjee S; Cutz E; Yeger H
    J Cyst Fibros; 2015 Mar; 14(2):182-93. PubMed ID: 25453871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evidence-based treatment of cystic fibrosis].
    Ringshausen FC; Hellmuth T; Dittrich AM
    Internist (Berl); 2020 Dec; 61(12):1212-1229. PubMed ID: 33201261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.